Pathogenesis of HIV-associated non-Hodgkin lymphoma

Current HIV Research

Volumn 2, Issue 3, 2004, Pages 215-221

  Killebrew, Deirdre ^a   Shiramizu, Bruce ^a  

^a Leahi Hospital   (United States)

Author keywords

HIV 1 associated malignancies; HIV 1 associated non Hodgkin's lymphoma; Human immunodeficiency virus; Sequential neoplasia

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER RISK; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; MALIGNANT TRANSFORMATION; MOUSE; MUTAGENESIS; NONHODGKIN LYMPHOMA; NONHUMAN; RETROVIRUS; REVIEW; VIRUS CARCINOGENESIS; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

B-LYMPHOCYTES; BIOLOGICAL MARKERS; CELL TRANSFORMATION, VIRAL; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOCOMPETENCE; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; MACROPHAGES; RISK FACTORS; VIRUS INTEGRATION;

EID: 3042753389     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570162043351237     Document Type: Review

References (63)

1. Arendt CW, Littman DR. (2001). Genome Biology. 2: 1030.1031-1030.1034.
2. Beatty J, Callanan JJ, Terry A, Jarrett O, Neil J. (1988). Journal of Virology. 72: 767-771.
3. Beral V, Jaffe HW, Weiss RA. (1991). Cancer, HIV and AIDS. In: Beral V, Jaffe HW, Weiss RA Eds, Cancer Surveys. Plainview, Cold Spring Harbor Laboratory Press. pp 1-5.
4. Beral V, Peterman T, Berkelman R. (1991). Lancet. 337: 805-809.
5. Berd D, Prehn RT. (1977). Journal of the National Cancer Institute. 58: 1729-1734.
6. Boshoff C, Weiss R. (2002). Nature Reviews. 2: 373-382.
7. Bower M, Fife K. (2001). HIV Medicine. 2: 141-145.
8. Brown PO. (1990). Current Topics in Microbiology and Immunology. 157: 19-48.
9. Campioni D, Corallini A, Zauli G, Possati L, Altavilla G, Barbanti-Brodano G. (1995). AIDS Research and Human Retroviruses. 11: 1039-1048.
10. Carbone A, Gaidano G. (2001). European Journal of Cancer. 37: 1184-1187.
11. Carteau S, Hoffmann C, Bushman F. (1998). Journal of Virology. 72: 4005-4014.
12. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. (1994). Science. 266: 1865-1869.
13. Cunto-Amesty G, Przybylski G, Honczarenko M, Monroe JG, Silberstein LE. (2000). Blood. 95: 1393-1399.
14. Dal Maso L, Franceschi S. (2003). The Lancet Oncology. 4: 110-119.
15. Foussat A, Wijdenes J, Bouchet L, Gaidano G, Neipel F, Balabanian K, Galanaud P, Couderc J, Emilie D. (1999). European Cytokine Network. 10: 501-508.
16. Frisch M, Biggar RJ, Engels EA, Goedert JJ. (2001). The Journal of the American Medical Association. 285: 1736-1745.
17. Goff SP. (1992). Annual Review of Genetics. 26: 527-544.
18. Grulich AE. (2000). The AIDS Reader. 10: 341-346.
19. Grulich AE, Wan X, Law MG, Milliken ST, Lewis CR, Garsia RJ, Gold J, Finlayson RJ, Cooper DA, Kaldor JM. (2000). AIDS (London, England). 14: 133-140.
20. Herndier BG, Shiramizu BT, Jewett NE, Aldape KD, Reyes GR, McGrath MS. (1992). Blood. 79: 1768-1774.
21. Jucker M, Roebroek AJM, Mautner J, Koch K, Eick D, Diehl V, Ven WJMVd, Tesch H. (1992). Oncogene. 7: 943-952.
22. Kirk O, Pedersen C, Cozzi-Lepri A, Antunes F, Miller V, Gatell JM, Katlama C, Lazzarin A, Skinhoj P, Barton SE. (2001). Blood. 98: 3406-3412.
23. Kitamura Y, Lee YMH, Coffin JM. (1992). Proceedings of the national Academy of Sciences of the United States of America. 89: 5532-5536.
24. Knowles DM, Pirog EC. (2001). European Journal of Cancer. 37: 1236-1250.
25. Knowles DM. (2003). Hematology/Oncology Clinics of North America. 17: 785-820.
26. Komanduri KV, Luce JA, McGrath MS, Herndier BG, Ng VL. (1996). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 13: 215-226.
27. Kuppers R, Klein U, Hansmann ML, Rajewsky K. (1999). The New England Journal of Medicine. 341: 1520-1529.
28. Kutza J, Fields K, Grimm TA, Clouse KA. (2002). Aids research and human retroviruses. 18: 619-625.
29. Levine A, Gill P, Meyer P. (1985). The Journal of the American Medical Association. 254: 1921-1925.
30. Levine A. (2000). Seminars in Oncology. 27: 442-453.
31. Levine A. (2000). Seminars in Oncology. 27: 389.
32. Liu C, Okruzhnov Y, Li H, Nicholas J. (2001). Journal of Virology. 75: 10933-10940.
33. Lodish H, Baltimore D, Berk A, Zipursky LS, Matsudaira P, Darnell J. (1995). Molecular Cell Biology. In: Eds, New York, New York, Scientific American, Inc. pp 334-336.
34. Lyn D, Bennett NA, Shiramizu BT, Herndier BG, Igietseme JU. (2001). Cellular and Molecular Biology (Noisy-le-grand, France). 47: 981-986.
35. Mack KD, Jin X, Yu S, Wei R, Kapp L, Green C, Herndier B, Abbey NW, Elbaggari A, Liu Y, McGrath MS. (2003). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 33: 308-320.
36. Maggiorella MT, Monardo F, Koanga-Mogtomo ML, Cioe L, Sernicola L, Corrias F, Baroni CD, Verani P, Titti F. (1998). Blood. 91: 3103-3111.
37. Majors J. (1990). Current Topics in Microbiology and Immunology. 157: 49-92.
38. McGrath M, Shiramizu B, Herndier B. (2000). Clonal HIV in the pathogenesis of AIDS-related lymphoma: sequential pathogenesis. In: Goedert JJ Eds, Infectious Causes of Cancer: Targets for Intervention. Totowa, NJ, Humana Press. pp. 231-242.
39. McGrath MS, Shiramizu B, Meeker TC, Kaplan LD, Herndier B. (1991). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 4: 408-415.
40. McGrath MS, Shiramizu BT, Herndier BG. (1995). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 8: 379-385.
41. Meeker TC, Shiramizu B, Kaplan L, Herndier B, Sanchez H, Grimaldi C, Baumgartner A, Rachlin A, Feigal E, Rosenblum M, McGrath MS. (1991). AIDS (London, England). 5: 669-674.
42. Ng VL, McGrath MS. (2002). November. Pathogenesis of HIV-Associated Lymphoma. HIV InSite Knowledge Base Chapter.
43. Nicholas J, Ruvolo VR, Burns WH, Sandford G, Wan X, Ciufo D, Hendrickson SB, Guo HG, Hayward GS, Reitz MS. (1997). Nature Medicine. 3: 287-292.
44. Ouweland AMWvd, Duijnhoven HLPv, Keizer GD, Dorssers LCJ, Ven WJMVd. (1990). Nucleic Acids Research. 18: 664.
45. Rabkin CS, Yang Q, Goedert JJ, Nguyen G, Mitsuya H, Sei S. (1999). Blood. 93: 1838-1842.
46. Roebroek AJM, Schalken JA, Bussemakers MJG, Heerikhuizen Hv, Onnekink C, Debruyne FMJ, Bloemers HPJ, Ven WJMVd. (1986). Molecular Biology Reports. 11: 117-125.
47. Roebroek AJM, Schalken JA, Leunissen JAM, Onnekink C, Bloemers HPJ, Ven WJMVd. (1986). The EMBO Journal. 5: 2197-2202.
48. Scadden DT. (2000). Neoplasms in Acquired Immunodeficiency Syndrome. In: Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E Eds, Cancer Medicine, 5th Edition. Hamilton, Ontario, BCDecker. pp 37: 1-21.
49. Scherdin U, Rhodes K, Breindl M. (1990). Journal of Virology. 64: 907-912.
50. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. (2002). Cell. 110: 521-529.
51. Shih C, Stoye JP, Coffin JM. (1988). Cell. 53: 531-537.
52. Shirai A, Cosentino M, Leitman-Klinman SF, Klinman DM. (1992). The Journal of Cinical Investigation. 89: 561-566.
53. Shiramizu B, Herndier B, Meeker T, Kaplan L, McGrath M. (1992). Journal of Clinical Oncology. 10: 383-389.
54. Shiramizu B, Herndier BG, McGrath MS. (1994). Cancer Research. 54: 2069-2072.
55. Sparano JA. (2003). Current Opinion in Oncology. 15: 372-378.
56. Stevens S, Griffith J. (1996). Journal of Virology. 70: 6459-6462.
57. Stevens SW, Griffith JD. (1994). Proceedings of the national Academy of Sciences of the United States of America. 91: 5557-5561.
58. Tirelli U, Bernardi D, Spina M, Vaccher E. (2002). Critical Reviews in Oncology/Hematology. 41: 299-315.
59. Varmus H. (1988). Science. 240: 1427-1435.
60. Vijaya S, Steffen DL, Robinson HL. (1986). Journal of Virology. 60: 683-692.
61. Vogel J, Hinrichs SH, Reynolds RK, Luciw PA, Jay G. (1988). Nature. 335: 606-611.
62. Vogt PK. (1997). Historical introduction to the general properties of retroviruses. In: Coffin JM, Hughes SH, Varmus HE Eds, Retroviruses. Plainview, Cold Spring Harbor Laboratory Press. pp. 1-26.
63. Zenger E, Abbey NW, Weinstein MD, Kapp L, Reis J, Gofman I, Millward C, Gascon R, Elbaggari A, Herndier BG, McGrath MS. (2002). Cancer Research. 62: 5536-5542.